Cala Health recently published a post-market surveillance study that demonstrates the long-term efficacy of its wrist-based wearable for people with essential tremor, finding that the device reduced patients’ tremor power by 71%. The Burlingame, California-based company was founded in 2014 as a Stanford University spinout. It makes a wrist-based wearable that uses electrical stimulation to temporarily relieve tremor symptoms.
Cala’s Real-World Study Validates its Wearable’s Long-Term Efficacy
Posted on October 5, 2022
Categories: Coping with ET, In the News
4 thoughts on “Cala’s Real-World Study Validates its Wearable’s Long-Term Efficacy”
Would like to know more about Cala wrist band.
The best and most up-to-date information about Cala Trio can be accessed on this website: https://calatrio.com/.
I would like to know how I go about getting a Cala Trio to treat my ET. I am becoming increasing unable to write, and eating and drinking has been a problem to do it in tidy fashion. My medications do not seem to touch my tremors on some days, at all. I am 67 years old, and have had ET for over 30 years.
The Cala Trio website has a lot of great information that should be helpful to you. https://calatrio.com/
Comments are closed.